![[Jcount.com]](https://www.jcount.com/wp-content/uploads/2014/08/jcount150X50.png)
![[Jcount.com]](https://www.jcount.com/wp-content/uploads/2014/08/jcountstartupslogo1.png)
What does AEGEA Medical do?
AEGEA Medical, is a manufacturer of medical and surgical instruments. This private medical device startup which focuses on developing proprietary and innovative water vapor treatment for women with abnormal uterine bleeding. The company develops innovative technology which is naturally as powerful as the women it aims at serving. The company was founded in 2008 for developing technology which aspires in using water vapor for treating a variety of women’s health conditions. It has an experienced management team and is supported by a committed investor group has established by portfolio of Intellectual Property.
How much AEGEA medical was funded?
AEGEA medical has raised $36 M in Series C funding on May 4th, 2015 from the investors Solas BioVentures, Medtronic, BioMed Ventures, Delphi Ventures, Covidien and Alloy Ventures.
Previous funding
$13.4M in Private Equity funding on May 25th, 2011 from Delphi Ventures, Alloy Ventures and Covidien Ventures.
$6M in Debt Financing on May 20th, 2013
What is next for AEGEA Medical?
AEGEA Medical has closed its Series C funding with the funds $36 M and has announced the completion of enrollement in its multi-center international pivotal trial. AEGEA Medical will use the latest funding raised for completing the submission of its PMA application to get approval from the FDA for marketing its endometrial ablation procedure for treating abnormal uterine bleeding in women.
What is next for AEGEA Medical?
AEGEA Medical was founded in 2007 by Paul Goeld. It has its headquarters in Redwood City, CA. This startup is developing technology which uses convective water vapor for treating menorrhagia or abnormal uterine bleeding, which nearly 1 in 5 women between the ages of 30 and 50 experience. Its Vapor System delivers a controlled, low pressure natural water vapor to uterine cavity to efficiently ablate the uterus’s inner lining. The technology delivers an adaptive water vapor in a simple physician’s office based procedure and takes just a few minutes to complete to reduce the uterine bleeding.
